Search research articles
Contact Us
Filters
Showing results (91-100 of 133) with videos related to
Page
of 14
Sort By:
Heart (British Cardiac Society)
|
June 27, 2007
Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events
B Nallamothu, K A A Fox, B M Kennelly, et al.
European Heart Journal
|
July 20, 2002
Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes; the GUSTO-IIb haemostasis substudy
K Kottke-Marchant, M C Bahit, C B Granger, et al.
Circulation
|
July 9, 2003
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction
L Wallentin, P Goldstein, P W Armstrong, et al.
Journal of the American College of Cardiology
|
November 30, 1999
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries
M G Cohen, C B Granger, E M Ohman, et al.
Heart (British Cardiac Society)
|
June 17, 2005
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns
P Kaul, L K Newby, Y Fu, et al.
The American Journal of Cardiology
|
December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries
E M Ohman, P W Armstrong, H D White, et al.
The American Journal of Medicine
|
October 24, 2000
Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry
M R Shah, C B Granger, B A Bart, et al.
Journal of the American College of Cardiology
|
January 13, 1998
Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries
E B Sgarbossa, S L Pinski, E J Topol, et al.
Clinical Chemistry
|
March 25, 1998
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators
R H Christenson, S H Duh, L K Newby, et al.
Circulation
|
March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I
K W Mahaffey, C B Granger, M A Sloan, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 133) with videos related to
Sort By:
Page
of 14
Heart (British Cardiac Society)
|
June 27, 2007
Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events
B Nallamothu, K A A Fox, B M Kennelly, et al.
European Heart Journal
|
July 20, 2002
Effect of hirudin vs heparin on haemostatic activity in patients with acute coronary syndromes; the GUSTO-IIb haemostasis substudy
K Kottke-Marchant, M C Bahit, C B Granger, et al.
Circulation
|
July 9, 2003
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction
L Wallentin, P Goldstein, P W Armstrong, et al.
Journal of the American College of Cardiology
|
November 30, 1999
Outcome of Hispanic patients treated with thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I and III trials. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries
M G Cohen, C B Granger, E M Ohman, et al.
Heart (British Cardiac Society)
|
June 17, 2005
Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns
P Kaul, L K Newby, Y Fu, et al.
The American Journal of Cardiology
|
December 30, 1999
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries
E M Ohman, P W Armstrong, H D White, et al.
The American Journal of Medicine
|
October 24, 2000
Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry
M R Shah, C B Granger, B A Bart, et al.
Journal of the American College of Cardiology
|
January 13, 1998
Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries
E B Sgarbossa, S L Pinski, E J Topol, et al.
Clinical Chemistry
|
March 25, 1998
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators
R H Christenson, S H Duh, L K Newby, et al.
Circulation
|
March 14, 1998
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I
K W Mahaffey, C B Granger, M A Sloan, et al.
Page
of 14